Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

NCT03127774

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adrenal Cortex Diseases, +16 more
Locations: Columbia University Medical Center New York, United States

View Trial Details

Active, not recruiting

HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer

NCT04403620

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Active, not recruiting

Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma

NCT04849871

Conditions: Breast Cancer, Breast Carcinoma, Breast Carcinoma In Situ, +12 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Active, not recruiting

Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

NCT04022343

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Active, not recruiting

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

NCT04586231

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Ironwood Cancer & Research Centers ( Site 0077) Chandler, Arizona, United States

Cedars Sinai Medical Center ( Site 0027) Los Angeles, California, United States

UCLA Hematology/Oncology - Santa Monica ( Site 0048) Los Angeles, California, United States

St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0095) Orange, California, United States

View all 184 locations

View Trial Details

Active, not recruiting

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

NCT04620603

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, not recruiting

A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

NCT03504397

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations: University of Arizona Phoenix, Arizona, United States

The University of Arizona Medical Center Tucson, Arizona, United States

CBCC Global Research, Inc. at Comprehensive Blood and Cancer Bakersfield, California, United States

City of Hope Nat'l Medical Center Duarte, California, United States

View all 220 locations

View Trial Details

Active, not recruiting

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

NCT03393884

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Mitchell Cancer Institute (University of South Alabama) Mobile, Alabama, United States

Gynecologic Oncology Associates (Hoag Hospital) Newport Beach, California, United States

Innovative Clinical Research Whittier, California, United States

View all 21 locations

View Trial Details

Active, not recruiting

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

NCT03482102

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

NCT02088645

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +14 more
Locations: University Hospital Basel, Clinic for radiology and nuclear medicine Basel, Switzerland

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions